Compound Library

SARM / REV-ERB Agonist

SLU-PP-332

Potent REV-ERBα/β dual agonist. Activates circadian clock genes, dramatically increases mitochondrial biogenesis and oxidative metabolism. Animal data shows 50% increase in running endurance without exercise. Suppresses lipogenesis. No human trials yet — among the most exciting metabolic research compounds.

Build protocol outline Open dose calculator TNHL ebooks
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.
Reference dose100–300 mg/day oral (research protocols)
Half-life4 hours
Risk flagmoderate
Regulatory noteResearch-only flag

Side effects and watch-outs

  • ⚠️ No human clinical data — all evidence from animal models
  • Potential disruption of circadian rhythm with incorrect timing (take in morning)
  • GI distress
  • Theoretical cardiovascular effects at high doses
  • Unknown long-term safety profile
  • Purity concerns — research chemical supply only